Stay updated with breaking news from Mark Berger. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Genprex, Inc. (NASDAQ:GNPX) has announced that data highlighting the potential of its gene therapy for Type 1 diabetes is being presented by its research...
24.02.2023 - EQS-Media / 24.02.2023 / 15:26 CET/CEST Results show statistically significant decreases in insulin requirements, increases in c-peptide levels and improvements in glucose tolerance compared to baseline Disruptive gene therapy approach developed ...
/PRNewswire/ -- Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies...
Genprex Inc. (NASDAQ:GNPX) has announced that its research collaborators at the University of Pittsburgh will present preclinical data highlighting the...
/PRNewswire/ -- Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies...